CD122 antibody

Ref. 3D-10R-6475

Produktinformation

• Name: CD122 antibody

Beschreibung

The CD122 antibody is a highly effective therapeutic tool that belongs to the class of activated monoclonal antibodies. It specifically targets CD122, a receptor for vasoactive intestinal peptide, which is involved in various physiological processes. This antibody has shown promising results in the treatment of autoimmune disorders, as it can neutralize autoantibodies and promote cytotoxic effects on target cells. Additionally, the CD122 antibody can be used in the development of chimeric receptors for immunotherapy purposes. With its high specificity and potency, this monoclonal antibody has gained significant attention in the field of Life Sciences. Its ability to induce necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell death makes it a valuable tool for cancer research and therapy. The CD122 antibody is derived from human monoclonal antibodies and has been extensively studied for its potential use in nuclear medicine, as well as its ability to enhance immune response and multidrug resistance.

• Marke: Biosynth